Revenue
$4.2b
-0.8% ↓ vs $4.3b
Significant items including a NZ$122m Tradelink write-down masked NZ$455m of underlying EBITDA, but leverage rose to 4.3x and the interim dividend
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY24 vs HY23
Revenue
$4.2b
-0.8% ↓ vs $4.3b
EBITDA
$455m
— vs —
Net profit after tax
−$120m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
−$126m
+37.9% ↑ vs −$203m
Declared dividend per share
—
— vs 18.0c
Operating profit
−$44m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Profit before tax
−$138m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$215m
-21.0% ↓ vs $272m
What changed
Net profit after tax fell to -NZ$120.0m from +NZ$92.0m (-230.4%), also unprecedented in the supplied history. Revenue was effectively flat at NZ$4.2b, down 0.8%, which the historical baseline treats as within the normal range (four-period mean -7.1%). The gap between the two stories is significant items, including a disclosed NZ$122.0m non-cash Tradelink write-down, with EBIT margin compressing to 6.2% from 8.4%.
EBITDA before significant items was still NZ$455.0m. Operating cash outflow narrowed to -NZ$126.0m from -NZ$203.0m, but inventories rose NZ$544.0m (+32.1%) to NZ$2.2b, net debt rose to NZ$2b (leverage 4.3x EBITDA), and no interim dividend was declared versus 18.0 cps in HY23.
What matters
Revenue is within the historical range and EBITDA before significant items of NZ$455.0m supports a 10%+ underlying EBITDA margin. The disclosed Tradelink write-down explains most of the NPAT-to-PBT divergence; the cleaner operating read is PBT growth of -200.7%, which still confirms HY24 earnings power has weakened materially from HY23 (EBIT margin -220bps).
Balance-sheet pressure is the new story. Inventory days rose to 96 from 72 (+24 days) and operating working capital expanded by NZ$1.6b year on year, while net debt climbed to NZ$2b, taking leverage to 4.3x EBITDA. Total assets of NZ$8.9b are above the historical range (mean NZ$8.2b), and equity contracted 6.2% to NZ$3.4b. This matters because it constrains capital-allocation flexibility just as trading conditions weaken.
Segment mix flags where the pain is concentrated. Distribution result fell to NZ$35.0m from NZ$65.0m (margin 4.2% vs 6.7%), Construction posted a -NZ$1.0m result, and the release flags NZ residential volumes -20%. Australia (34.0% of revenue) held its 5.4% margin, providing the only stable anchor.
Expectations
HY23 represented 50.6% of FY23 revenue but only 39.1% of FY23 NPAT, so the historical shape skews earnings to the second half. Annualising HY24 revenue gives roughly NZ$8.5b, broadly in line with FY23, but the second-half NPAT bridge requires a recovery the release does not quantify.
The gap that matters is between underlying EBITDA of NZ$455.0m and the reported loss: without management quantifying further significant-item exposure and the cash cost of inventory unwind, the path to a clean second half is not anchored by anything in this release.
Quality of result
First, cash conversion is weak: OCF/EBITDA was -27.7% in the half, with inventory build (NZ$544.0m) absorbing the underlying earnings. Pre-lease free cash flow of -NZ$314.0m did improve from -NZ$450.0m in HY23 but sits at the lower edge of Annolyse's historical baseline (four-period mean -NZ$152.2m). The improvement reflects lower capex (NZ$188.0m vs NZ$247.0m, capex intensity 4.4%) rather than stronger trading cash flow.
Second, EBITDA before significant items is the figure management is presenting as durable, but the historical record now contains an unprecedented PBT and NPAT outcome together with leverage at 4.3x EBITDA and ROE of -3.5% (versus prior 2.5%). The combination of seasonally negative operating cash, a NZ$1.6bn working-capital expansion year on year, and a suspended dividend suggests the underlying earnings need to be demonstrated in second-half cash conversion, not just in the EBITDA-before-significant-items line.
Unresolved
This briefing cannot assess covenant terms, the recoverability of remaining Tradelink and Construction carrying values, or management's specific second-half cash-flow plan, none of which are quantified in the supplied release.
Chat
Ask follow-up questions about Fletcher Building's HY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
2024 Interim Financial Results
HY24 / financial reportResults Announcement
HY24 / results announcementResults Presentation
HY24 / results presentationStock Exchange Notice
HY24 / results release2023 Interim Financial Results
HY23 / financial reportResults Announcement
HY23 / results announcementResults Announcement
HY23 / results releaseAnnual Report 2023
FY23 / financial reportResults Announcement
FY23 / results announcementResults Announcement
FY23 / results releaseASM Presentation
HY24 / commentaryFletcher Building notifies Moody’s outlook amendment
HY24 / commentaryHY24 Results Webcast Details
HY24 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Leverage and balance-sheet risk
Net debt / EBITDA is 4.33x for this result.
Earnings quality and statutory distortions
This result includes a statutory earnings-quality distortion flag.
Working-capital pressure
Inventory days were 96 days, +24 days versus the prior comparable period.
ROE and capital efficiency
ROE was -3.5%, -6.0pp versus the prior comparable period.
Get the next Fletcher Building briefing and related NZX reporting-season updates by email.